Hall of the House of Representatives
95th General Assembly - Regular Session, 2025
Amendment Form
______________________________________________________________________
Subtitle of House Bill 1301
TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY ACT.
______________________________________________________________________
Amendment No. 3 to House Bill 1301
Amend House Bill 1301 as engrossed H2/20/25 (version: 2/20/25 11:51:11 AM):
Page 3, line 16, delete "insurer; or" and substitute "insurer;"
AND
Page 3, delete line 19, and substitute the following:
"insurer's commencement of operations subject to this subchapter; or
(D)(i) For a healthcare provider denied an exemption under
this section, any consecutive six-month period during the twelve (12) months
before the healthcare provider's request for a new evaluation.
(ii) A healthcare provider may request that the
healthcare insurer perform a new evaluation twelve (12) months after the most
recent denial."
AND
Page 4, delete line 12, and substitute the following:
"to or termination of the election.
(3) If, in the most recent six-month evaluation period, the
healthcare insurer approved or would have approved less than eighty percent
(80%) of the prior authorization requests submitted by a healthcare provider
for a particular healthcare service, the healthcare provider shall not be
eligible for inclusion under an exemption extended to healthcare providers
under the same tax identification number under this subsection."
*.ANS360*
ANS360 - 03-11-2025 04:00:53 Page 1 of 4

AND
Page 10, delete line 22, and substitute the following:
"(f)(1) Upon request, a healthcare insurer or a pharmacy benefits
manager shall send"
AND
Page 11, delete lines 7 through 18
AND
Page 12, delete line 18, and substitute the following:
"subdivision (b)(1) of this section should be granted.
(4) The criteria established under subdivision (b)(3) of this
section shall include criteria related to the cost and the safety of the
prescription drug, medicine, biological product, pharmaceutical, or
pharmaceutical service."
AND
Page 12, line 19, delete "(4)" and substitute "(5)"
AND
Page 12, line 25, delete "(5)" and substitute "(6)"
AND
Page 12, line 28, delete "(6)" and substitute "(7)"
AND
Page 12, line 32, delete "(7)" and substitute "(8)"
ANS360 - 03-11-2025 04:00:53 Amendment No. 1 to House Bill 1301 Page 2 of 4

AND
Page 12, line 36, delete "(8)" and substitute "(9)"
AND
Page 13, line 2, delete "subdivision (b)(5)" and substitute "subdivision
(b)(6)"
AND
Page 13, delete lines 16 through 35, and substitute the following:
"SECTION 10. Arkansas Code ยง 23-99-1129 is amended to read as follows:
23-99-1129. Appeals process for disallowance of prior authorization.
(a) If the Arkansas State Board of Pharmacy and the Arkansas State
Medical Board, jointly, disallow a prior authorization of a prescription
drug, medicine, biological product, pharmaceutical, or pharmaceutical service
requested under ยง 23-99-1128, a healthcare insurer, pharmacy benefits
manager, or other interested party may file an appeal to the State Insurance
Department within ninety (90) days of the disallowance of the prior
authorization.
(b) The healthcare insurer, pharmacy benefits manager, or other
interested party shall provide a notice of seven (7) days to the Arkansas
State Board of Pharmacy and the Arkansas State Medical Board of the
healthcare insurer's, pharmacy benefits manager's, or other interested
party's intent to file an appeal.
(c) No later than the thirtieth day after the date a healthcare
insurer, pharmacy benefits manager, or other interested party files an appeal
under subsection (a) of this section, the Insurance Commissioner shall
appoint an independent review organization to review the appeal.
(c)(d) A healthcare insurer, pharmacy benefits manager, or other
interested party that files an appeal under subsection (a) of this section
shall pay for the independent review organization appointed under subsection
(b)(c) of this section to review the appeal.
(e)(1) If a healthcare insurer, pharmacy benefits manager, or other
interested party succeeds in its appeal and overturns the decision of the
ANS360 - 03-11-2025 04:00:53 Amendment No. 1 to House Bill 1301 Page 3 of 4

Arkansas State Board of Pharmacy and the Arkansas State Medical Board, the
healthcare insurer, pharmacy benefits manager, or other interested party
shall be reimbursed for fifty percent (50%) of the cost remitted to the
independent review organization under subsection (d) of this section.
(2) The Arkansas State Board of Pharmacy and the Arkansas State
Medical Board shall each provide twenty-five percent (25%) of the total
reimbursement to the healthcare insurer, pharmacy benefits manager, or other
interested party under subdivision (e)(1) of this section.
(d)(f) A healthcare insurer, pharmacy benefits manager, or other
interested party is bound by the independent review organization's
determination of the appeal under this section."
The Amendment was read ________________________________________________________________________________
By: Representative L. Johnson
ANS/ANS - 03-11-2025 04:00:53 _________________________
ANS360 Chief Clerk
ANS360 - 03-11-2025 04:00:53 Amendment No. 1 to House Bill 1301 Page 4 of 4

[DELETED:  PA    (   ( (]
[DELETED:  P" (]
[DELETED:  P"2(((((]
[DELETED:  P (( _ C]